位置:首页 > 蛋白库 > GALC_MOUSE
GALC_MOUSE
ID   GALC_MOUSE              Reviewed;         684 AA.
AC   P54818; O35151; Q3U3H7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   03-AUG-2022, entry version 154.
DE   RecName: Full=Galactocerebrosidase {ECO:0000305};
DE            Short=GALCERase;
DE            EC=3.2.1.46 {ECO:0000269|PubMed:8769874};
DE   AltName: Full=Galactocerebroside beta-galactosidase;
DE   AltName: Full=Galactosylceramidase {ECO:0000250|UniProtKB:P54803};
DE   AltName: Full=Galactosylceramide beta-galactosidase;
DE   Flags: Precursor;
GN   Name=Galc {ECO:0000312|MGI:MGI:95636};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, TISSUE
RP   SPECIFICITY, AND ROLE IN DISEASE.
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=8769874; DOI=10.1046/j.1471-4159.1996.66031118.x;
RA   Sakai N., Inui K., Tatsumi N., Fukushima H., Nishigaki T., Taniike M.,
RA   Nishimoto J., Tsukamoto H., Yanagihara I., Ozono K., Okada S.;
RT   "Molecular cloning and expression of cDNA for murine galactocerebrosidase
RT   and mutation analysis of the twitcher mouse, a model of Krabbe's disease.";
RL   J. Neurochem. 66:1118-1124(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Luzi P., Victoria T., Wenger D.A.;
RT   "Genomic organization of the mouse galactocerebrosidase (GALC) gene.";
RL   Submitted (MAY-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=NOD;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=10861297; DOI=10.1093/hmg/9.11.1699;
RA   Tohyama J., Vanier M.T., Suzuki K., Ezoe T., Matsuda J., Suzuki K.;
RT   "Paradoxical influence of acid beta-galactosidase gene dosage on phenotype
RT   of the twitcher mouse (genetic galactosylceramidase deficiency).";
RL   Hum. Mol. Genet. 9:1699-1707(2000).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 40-684 IN COMPLEX WITH GALACTOSE,
RP   ACTIVE SITE, GLYCOSYLATION AT ASN-300; ASN-379; ASN-403 AND ASN-558, AND
RP   DISULFIDE BOND.
RX   PubMed=21876145; DOI=10.1073/pnas.1105639108;
RA   Deane J.E., Graham S.C., Kim N.N., Stein P.E., McNair R.,
RA   Cachon-Gonzalez M.B., Cox T.M., Read R.J.;
RT   "Insights into Krabbe disease from structures of galactocerebrosidase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:15169-15173(2011).
CC   -!- FUNCTION: Hydrolyzes the galactose ester bonds of glycolipids such as
CC       galactosylceramide and galactosylsphingosine (PubMed:8769874,
CC       PubMed:10861297). Enzyme with very low activity responsible for the
CC       lysosomal catabolism of galactosylceramide, a major lipid in myelin,
CC       kidney and epithelial cells of small intestine and colon (By
CC       similarity). {ECO:0000250|UniProtKB:P54803,
CC       ECO:0000269|PubMed:10861297, ECO:0000269|PubMed:8769874}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-galactosyl-(1<->1')-N-acylsphing-4-enine + H2O = an
CC         N-acylsphing-4-enine + D-galactose; Xref=Rhea:RHEA:14297,
CC         ChEBI:CHEBI:4139, ChEBI:CHEBI:15377, ChEBI:CHEBI:18390,
CC         ChEBI:CHEBI:52639; EC=3.2.1.46;
CC         Evidence={ECO:0000269|PubMed:8769874};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14298;
CC         Evidence={ECO:0000305|PubMed:8769874};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a D-galactosylceramide + H2O = an N-acyl-sphingoid base + D-
CC         galactose; Xref=Rhea:RHEA:43412, ChEBI:CHEBI:4139, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:36498, ChEBI:CHEBI:83273;
CC         Evidence={ECO:0000269|PubMed:10861297};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43413;
CC         Evidence={ECO:0000305|PubMed:10861297};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=beta-D-galactosyl-(1<->1)-sphing-4-enine + H2O = D-galactose +
CC         sphing-4-enine; Xref=Rhea:RHEA:43908, ChEBI:CHEBI:4139,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:57756, ChEBI:CHEBI:57934;
CC         Evidence={ECO:0000250|UniProtKB:P54803};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43909;
CC         Evidence={ECO:0000250|UniProtKB:P54803};
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Detected in brain and kidney.
CC       {ECO:0000269|PubMed:8769874}.
CC   -!- DISEASE: Note=Defects in Galc are the cause of the 'twitcher'
CC       phenotype; an autosomal recessive leukodystrophy similar to the human
CC       disease (Krabbe disease). This deficiency results in the insufficient
CC       catabolism of several galactolipids that are important in the
CC       production of normal myelin.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 59 family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-17 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB71823.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH86671.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA07560.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D38557; BAA07560.1; ALT_INIT; mRNA.
DR   EMBL; AF003886; AAB71823.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AF003870; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003871; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003872; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003873; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003874; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003875; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003876; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003877; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003878; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003879; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003880; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003881; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003882; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003883; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003884; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AF003885; AAB71823.1; JOINED; Genomic_DNA.
DR   EMBL; AK154760; BAE32809.1; -; mRNA.
DR   EMBL; CH466549; EDL18937.1; -; Genomic_DNA.
DR   EMBL; BC086671; AAH86671.1; ALT_INIT; mRNA.
DR   CCDS; CCDS36517.1; -.
DR   RefSeq; NP_032105.2; NM_008079.4.
DR   PDB; 3ZR5; X-ray; 2.10 A; A=40-684.
DR   PDB; 3ZR6; X-ray; 2.44 A; A=40-684.
DR   PDB; 4CCC; X-ray; 2.09 A; A=41-684.
DR   PDB; 4CCD; X-ray; 1.97 A; A=41-684.
DR   PDB; 4CCE; X-ray; 2.06 A; A=41-684.
DR   PDB; 4UFH; X-ray; 2.16 A; A=41-684.
DR   PDB; 4UFI; X-ray; 2.40 A; A=41-684.
DR   PDB; 4UFJ; X-ray; 2.20 A; A=41-684.
DR   PDB; 4UFK; X-ray; 2.40 A; A=43-684.
DR   PDB; 4UFL; X-ray; 2.40 A; A=43-684.
DR   PDB; 4UFM; X-ray; 2.40 A; A=43-684.
DR   PDB; 5NXB; X-ray; 3.60 A; A/B=41-684.
DR   PDB; 6Y6S; X-ray; 2.10 A; A=41-684.
DR   PDB; 6Y6T; X-ray; 2.25 A; A=41-684.
DR   PDBsum; 3ZR5; -.
DR   PDBsum; 3ZR6; -.
DR   PDBsum; 4CCC; -.
DR   PDBsum; 4CCD; -.
DR   PDBsum; 4CCE; -.
DR   PDBsum; 4UFH; -.
DR   PDBsum; 4UFI; -.
DR   PDBsum; 4UFJ; -.
DR   PDBsum; 4UFK; -.
DR   PDBsum; 4UFL; -.
DR   PDBsum; 4UFM; -.
DR   PDBsum; 5NXB; -.
DR   PDBsum; 6Y6S; -.
DR   PDBsum; 6Y6T; -.
DR   AlphaFoldDB; P54818; -.
DR   SMR; P54818; -.
DR   BioGRID; 199817; 2.
DR   STRING; 10090.ENSMUSP00000021390; -.
DR   BindingDB; P54818; -.
DR   ChEMBL; CHEMBL2218; -.
DR   SwissLipids; SLP:000001418; -.
DR   CAZy; GH59; Glycoside Hydrolase Family 59.
DR   GlyGen; P54818; 6 sites.
DR   iPTMnet; P54818; -.
DR   PhosphoSitePlus; P54818; -.
DR   EPD; P54818; -.
DR   MaxQB; P54818; -.
DR   PaxDb; P54818; -.
DR   PeptideAtlas; P54818; -.
DR   PRIDE; P54818; -.
DR   ProteomicsDB; 267416; -.
DR   Antibodypedia; 26266; 239 antibodies from 28 providers.
DR   DNASU; 14420; -.
DR   Ensembl; ENSMUST00000021390; ENSMUSP00000021390; ENSMUSG00000021003.
DR   GeneID; 14420; -.
DR   KEGG; mmu:14420; -.
DR   UCSC; uc007olf.2; mouse.
DR   CTD; 2581; -.
DR   MGI; MGI:95636; Galc.
DR   VEuPathDB; HostDB:ENSMUSG00000021003; -.
DR   eggNOG; ENOG502QQ1Q; Eukaryota.
DR   GeneTree; ENSGT00390000003303; -.
DR   HOGENOM; CLU_015456_2_0_1; -.
DR   InParanoid; P54818; -.
DR   OMA; VASDNLW; -.
DR   OrthoDB; 364933at2759; -.
DR   PhylomeDB; P54818; -.
DR   TreeFam; TF312985; -.
DR   BRENDA; 3.2.1.46; 3474.
DR   Reactome; R-MMU-1660662; Glycosphingolipid metabolism.
DR   BioGRID-ORCS; 14420; 3 hits in 73 CRISPR screens.
DR   ChiTaRS; Galc; mouse.
DR   PRO; PR:P54818; -.
DR   Proteomes; UP000000589; Chromosome 12.
DR   RNAct; P54818; protein.
DR   Bgee; ENSMUSG00000021003; Expressed in stroma of bone marrow and 227 other tissues.
DR   ExpressionAtlas; P54818; baseline and differential.
DR   Genevisible; P54818; MM.
DR   GO; GO:0005764; C:lysosome; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; HDA:MGI.
DR   GO; GO:0004336; F:galactosylceramidase activity; IDA:UniProtKB.
DR   GO; GO:0006683; P:galactosylceramide catabolic process; IDA:MGI.
DR   GO; GO:0042552; P:myelination; IMP:MGI.
DR   Gene3D; 3.20.20.70; -; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR001286; Glyco_hydro_59.
DR   InterPro; IPR035394; Glyco_hydro_59_dom.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   PANTHER; PTHR15172; PTHR15172; 1.
DR   Pfam; PF02057; Glyco_hydro_59; 1.
DR   Pfam; PF17387; Glyco_hydro_59M; 1.
DR   PRINTS; PR00850; GLHYDRLASE59.
DR   SUPFAM; SSF51445; SSF51445; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Disulfide bond; Glycoprotein; Glycosidase; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Lysosome; Reference proteome; Signal;
KW   Sphingolipid metabolism.
FT   SIGNAL          1..42
FT                   /evidence="ECO:0000250"
FT   CHAIN           43..684
FT                   /note="Galactocerebrosidase"
FT                   /id="PRO_0000012232"
FT   ACT_SITE        198
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000269|PubMed:21876145"
FT   ACT_SITE        274
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000269|PubMed:21876145"
FT   BINDING         109
FT                   /ligand="substrate"
FT   BINDING         151
FT                   /ligand="substrate"
FT   BINDING         197
FT                   /ligand="substrate"
FT   BINDING         396
FT                   /ligand="substrate"
FT   CARBOHYD        300
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21876145"
FT   CARBOHYD        379
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21876145"
FT   CARBOHYD        403
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21876145"
FT   CARBOHYD        558
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21876145"
FT   CARBOHYD        601
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        645
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        287..394
FT                   /evidence="ECO:0000269|PubMed:21876145"
FT   CONFLICT        376
FT                   /note="G -> A (in Ref. 2; AAB71823)"
FT                   /evidence="ECO:0000305"
FT   STRAND          42..45
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          51..54
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          57..62
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   TURN            67..73
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   HELIX           78..87
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   TURN            89..91
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          96..102
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          105..107
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          109..112
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          127..129
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   HELIX           130..140
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          145..151
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   HELIX           155..158
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   HELIX           168..186
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   HELIX           203..215
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          222..228
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   HELIX           233..239
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   HELIX           241..246
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          249..254
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   HELIX           261..266
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          269..276
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   HELIX           282..299
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          303..307
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          309..311
FT                   /evidence="ECO:0007829|PDB:4CCC"
FT   TURN            318..321
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          323..326
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   TURN            330..332
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   HELIX           340..348
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          356..359
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          369..374
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          376..378
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          380..385
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   HELIX           389..391
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          395..397
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          407..413
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   HELIX           415..417
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          422..429
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          437..446
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          449..451
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          453..458
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          460..468
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          488..492
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          500..503
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          508..512
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          514..518
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          526..531
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          545..552
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          558..567
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   TURN            570..572
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          574..581
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   HELIX           585..590
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          592..599
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   TURN            600..602
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          603..609
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          614..620
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          628..636
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          639..644
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          647..654
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          662..670
FT                   /evidence="ECO:0007829|PDB:4CCD"
FT   STRAND          673..683
FT                   /evidence="ECO:0007829|PDB:4CCD"
SQ   SEQUENCE   684 AA;  77256 MW;  DD4BD45AE898C524 CRC64;
     MANSQPKASQ QRQAKVMTAA AGSASRVAVP LLLCALLVPG GAYVLDDSDG LGREFDGIGA
     VSGGGATSRL LVNYPEPYRS EILDYLFKPN FGASLHILKV EIGGDGQTTD GTEPSHMHYE
     LDENYFRGYE WWLMKEAKKR NPDIILMGLP WSFPGWLGKG FSWPYVNLQL TAYYVVRWIL
     GAKHYHDLDI DYIGIWNERP FDANYIKELR KMLDYQGLQR VRIIASDNLW EPISSSLLLD
     QELWKVVDVI GAHYPGTYTV WNAKMSGKKL WSSEDFSTIN SNVGAGCWSR ILNQNYINGN
     MTSTIAWNLV ASYYEELPYG RSGLMTAQEP WSGHYVVASP IWVSAHTTQF TQPGWYYLKT
     VGHLEKGGSY VALTDGLGNL TIIIETMSHQ HSMCIRPYLP YYNVSHQLAT FTLKGSLREI
     QELQVWYTKL GTPQQRLHFK QLDTLWLLDG SGSFTLELEE DEIFTLTTLT TGRKGSYPPP
     PSSKPFPTNY KDDFNVEYPL FSEAPNFADQ TGVFEYYMNN EDREHRFTLR QVLNQRPITW
     AADASSTISV IGDHHWTNMT VQCDVYIETP RSGGVFIAGR VNKGGILIRS ATGVFFWIFA
     NGSYRVTADL GGWITYASGH ADVTAKRWYT LTLGIKGYFA FGMLNGTILW KNVRVKYPGH
     GWAAIGTHTF EFAQFDNFRV EAAR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024